Page last updated: 2024-11-05

dimethyl phthalate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Dimethyl phthalate (DMP) is a synthetic compound used as a plasticizer in a wide range of products, including polyvinyl chloride (PVC) plastics, adhesives, and coatings. It is a colorless, odorless liquid with a high boiling point. DMP is produced by the reaction of phthalic anhydride with methanol. It is not considered to be highly toxic, but exposure to high concentrations can cause respiratory irritation and skin sensitization. DMP has been linked to endocrine disruption in animals, and its use in certain products, such as children's toys, has been restricted in some countries. Research on DMP focuses on its environmental fate, potential health effects, and alternative plasticizers. The compound's widespread use, its persistence in the environment, and its potential effects on human health make it a subject of ongoing research and regulatory scrutiny.'

dimethyl phthalate: used as plasticizer in computer mouse; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8554
CHEMBL ID323348
CHEBI ID4609
SCHEMBL ID34630
MeSH IDM0083053

Synonyms (128)

Synonym
BIDD:ER0349
MLS002177801
smr000777937
1,2-dimethyl benzene-1,2-dicarboxylate
EN300-18366
ent 262
wln: 1ovr bvo1
phthalic acid, dimethyl ester
phthalsaeuredimethylester
avolin
dimethyl benzene-o-dicarboxylate
unimoll dm
fermine
dimethyl 1,2-benzenedicarboxylate
solvanom
1,dimethyl ester
palatinol m
phthalic acid methyl ester
nsc15398
dimethyl o-phthalate
solvarone
nsc-15398
NTM ,
dmf, insect repellent
mipax
1,2-benzenedicarboxylic acid, dimethyl ester
benzene,1,2-dicarboxylic acid,dimethyl ester (phthalic acid,dimethyl ester)
inchi=1/c10h10o4/c1-13-9(11)7-5-3-4-6-8(7)10(12)14-2/h3-6h,1-2h
NCGC00090692-01
ccris 2674
rcra waste number u102
repeftal
einecs 205-011-6
dmf (insect repellant)
phtalate de dimethyle [iso-french]
phthalic acid dimethyl ester
epa pesticide chemical code 028002
dimethylphthalate
hsdb 1641
dimethylester kyseliny ftalove [czech]
nsc 15398
phthalsaeuredimethylester [german]
dimethyl benzeneorthodicarboxylate
dimethyl phthalate [bsi:iso]
caswell no. 380
ai3-00262
rcra waste no. u102
dimethyl phthalate
131-11-3
dimethyl phthalate, >=99%
NCGC00090692-02
NCGC00090692-03
bdbm50090983
1,2-benzenedicarboxylic acid 1,2-dimethyl ester
dimethyl benzene-1,2-dicarboxylate
chebi:4609 ,
dimethylphtalate
CHEMBL323348 ,
P0302
NCGC00090692-04
NCGC00090692-05
phtalate de dimethyle
1,2-benzenedicarboxylic acid, 1,2-dimethyl ester
ec 205-011-6
unii-08x7f5udjm
dimethylester kyseliny ftalove
dimethyl phthalate [usp]
08x7f5udjm ,
dtxsid3022455 ,
NCGC00254947-01
tox21_301045
dtxcid502455
cas-131-11-3
tox21_113536
tox21_202145
NCGC00259694-01
benzene-1,2-dicarboxylic acid dimethyl ester
STL283931
AKOS008969337
density standard 1191 kg/m3
FT-0625095
S5378
SCHEMBL34630
dimethyl phthalate [iso]
dimethyl phthalate [mi]
dimethyl phthalate [ii]
dimethyl phthalate [who-dd]
dimethyl phthalate [inci]
dimethyl phthalate [hsdb]
dimethyl phthalate [mart.]
NCGC00090692-06
dimethyl 1,2-benzendicarboxylate
1,2-dimethyl phthalate
kodaflex dmp
uniplex 110
kemester dmp
dimethyl orthophthalate
benzenedicarboxylic acid, dimethyl ester
density standard 1191 kg/m3, h&d fitzgerald ltd. quality
mfcd00008425
dimethyl phthalate, saj special grade, >=99.0%
dimethyl phthalate, pestanal(r), analytical standard
dimethyl phthalate, 99%
dimethyl phthalate, ar,99%
dimethyl phthalate, cp,99%
phthalic acid, bis-methyl ester
J-005938
Z57902306
DB13336
dimethyl phthalate 5000 microg/ml in methanol
Q423551
AMY40794
phthalic acid dimethyl ester (d6)
CCG-266531
CS-0013572
HY-N7106
BS-20466
phthalic acid, bis-methyl ester 1000 microg/ml in acetonitrile
dimethylphthalate-13c2
ftalato di metile
bisoflex dmp
dimethyl phthalate (mart.)
usepa/opp pesticide code: 028002
caswell no 380
phthalsauredimethylester
dimethyl phthalate (ii)
fifra 028002
1,2 benzene dicarboxylacid, dimethylester

Research Excerpts

Overview

Dimethyl phthalate (DMP) is a ubiquitous pollutant. DMP is very harmful to organisms due to its mutagenicity, teratogenicity and carcinogenicity.

ExcerptReferenceRelevance
"Dimethyl phthalate (DMP) is a ubiquitous pollutant that is very harmful to organisms due to its mutagenicity, teratogenicity and carcinogenicity. "( Response of Pseudomonas fluorescens to dimethyl phthalate.
Chen, W; Liu, Z; Lv, Z; Shi, Y; Wang, C; Wang, J; Wang, Z; Xu, W; You, Y, 2019
)
2.23

Treatment

ExcerptReferenceRelevance
"Dimethyl phthalate (DMP) was treated via wet oxygen oxidation process (WOP). "( Decomposition and Mineralization of Dimethyl Phthalate in an Aqueous Solution by Wet Oxidation.
Chang, CC; Chang, CF; Chang, CY; Chen, SY; Chen, YH; Chiang, SW; Chiu, CY; Hung, ZS; Ji, DR; Shie, JL; Tseng, JY; Yuan, MH, 2015
)
2.13

Toxicity

ExcerptReferenceRelevance
" LD50 values indicate that SS, NAP, and PNP were more toxic (8."( Developmental toxicity of nine selected compounds following prenatal exposure in the mouse: naphthalene, p-nitrophenol, sodium selenite, dimethyl phthalate, ethylenethiourea, and four glycol ether derivatives.
Booth, GM; Bradshaw, WS; Carter, MW; Hardin, BD; Plasterer, MR; Schuler, RL, 1985
)
0.47
" However, high-dose treatment with either DEP or DMP resulted in changes in food and water consumption paralleling the body weight reductions, suggesting that apparent toxic effects on maternal body weight may reflect PAE/feed unpalatability."( Developmental toxicity evaluation of diethyl and dimethyl phthalate in rats.
Field, EA; George, JD; Marr, MC; Morrissey, RE; Myers, CB; Price, CJ; Schwetz, BA; Sleet, RB, 1993
)
0.54
" Our data indicate an urgent need for LS waste management guidelines and for adequate information regarding toxic outcomes that may arise from human exposure."( Luminescent threat: toxicity of light stick attractors used in pelagic fishery.
Bagattini, R; Barretto, FP; Bechara, EJ; da Silva, AL; de Arruda Campos, IP; de Medeiros, MH; de Moura, RA; de Oliveira, AA; de Oliveira, TF; Di Mascio, P; Loureiro, AP, 2014
)
0.4
" These results described for the first time the adverse effects exerted by DMP on aquatic plants, contributing to highlight the environmental risk associated to the presence of this compound in the aquatic ecosystem."( Ecotoxicological and genotoxic effects of dimethyl phthalate (DMP) on Lemna minor L. and Spirodela polyrhiza (L.) Schleid. plants under a short-term laboratory assay.
Carloni, S; Cerasa, M; Iannilli, V; Passatore, L; Pietrini, F; Sciacca, G; Zacchini, M, 2022
)
0.99

Bioavailability

ExcerptReferenceRelevance
" As the esters became more lipophilic and less hydrophilic, the rate of absorption was reduced."( In vitro absorption of some o-phthalate diesters through human and rat skin.
Dugard, PH; Ramsey, JD; Rhodes, C; Scott, RC, 1987
)
0.27
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" stephensi Liston, using a "free choice," dose-response testing procedure on rabbits."( Comparative sensitivity of four Anopheles (Diptera: Culicidae) to five repellents.
Hallam, JA; Robert, LL; Roberts, LW; Seeley, DC; Wirtz, RA, 1991
)
0.28
" While only DEHP treatment reduced maternal weight gain during the entire dosing period by about 15 g, both DEHP and DINP reduced pregnancy weight gain to GD 21 by 24 g and 14 g, respectively."( Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat.
Furr, J; Gray, LE; Ostby, J; Parks, L; Price, M; Veeramachaneni, DN, 2000
)
0.31
" The dose-response curves obtained were verified using the Weibull fitting function."( Eco-toxicological bioassay of atmospheric fine particulate matter (PM2.5) with Photobacterium Phosphoreum T3.
Shi, C; Wang, W; Yan, Y; Yang, Y; Zhou, B, 2016
)
0.43
" In conclusion, we have developed a reliable image analysis method that can be used to facilitate dose-response studies for the reproducible induction of MNGs by in utero phthalate exposure."( Validation of an automated counting procedure for phthalate-induced testicular multinucleated germ cells.
Bai, CY; Boekelheide, K; Conley, JM; Gray, LE; Lambright, C; Spade, DJ, 2018
)
0.48
" Besides, comet assay indicated that there was a dose-response relationship between the DNA damage and phthalate dose, following DMP > DOP > BBP."( Phthalate induced oxidative stress and DNA damage in earthworms (Eisenia fetida).
Gao, J; Li, X; Song, P; Wang, J; Zhang, C; Zhu, L, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
phthalate ester
diesterA diester is a compound containing two ester groups.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.03860.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency2.74730.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency11.10120.000221.22318,912.5098AID743035; AID743036
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.72340.000214.376460.0339AID588532
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency0.00150.003041.611522,387.1992AID1159553
retinoid X nuclear receptor alphaHomo sapiens (human)Potency38.78160.000817.505159.3239AID1159527; AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency12.98720.001530.607315,848.9004AID1224841; AID1224842; AID1224849
pregnane X nuclear receptorHomo sapiens (human)Potency30.82490.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency24.88540.000229.305416,493.5996AID743069; AID743075; AID743078; AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency28.18380.001024.504861.6448AID588534
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00250.023723.228263.5986AID588543
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.47270.000323.4451159.6830AID743066
Cellular tumor antigen p53Homo sapiens (human)Potency0.24490.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID460407Partition coefficient, log P by shake flask method2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
AID203948Inhibition of [3H]citalopram binding to the serotonin transporter in cynomolgus (macaca fascicularis) monkey caudate putamen.2000Journal of medicinal chemistry, Aug-10, Volume: 43, Issue:16
2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters.
AID288185Permeability coefficient through artificial membrane in presence of stirred water layer2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1371097Octanol-water partition coefficient, log P of the compound at 1 mg by RP-HPLC analysis2017Bioorganic & medicinal chemistry letters, 04-15, Volume: 27, Issue:8
Adamantyl- and other polycyclic cage-based conjugates of desferrioxamine B (DFOB) for treating iron-mediated toxicity in cell models of Parkinson's disease.
AID460406Partition coefficient, log P by RP-HPLC2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID460408Partition coefficient, log P in presence of Fe(3+) by RP-HPLC2010Journal of medicinal chemistry, Feb-11, Volume: 53, Issue:3
Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload.
AID64209Inhibition of [3H]WIN-35428 binding to the dopamine transporter in cynomolgus (macaca fascicularis) monkey caudate putamen.2000Journal of medicinal chemistry, Aug-10, Volume: 43, Issue:16
2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters.
AID288191Membrane retention in permeability experiment with artificial membrane2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (267)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (12.73)18.7374
1990's14 (5.24)18.2507
2000's69 (25.84)29.6817
2010's114 (42.70)24.3611
2020's36 (13.48)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.42 (24.57)
Research Supply Index5.62 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index86.45 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (1.09%)6.00%
Case Studies5 (1.82%)4.05%
Observational0 (0.00%)0.25%
Other266 (97.08%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]